Targeting Cancer With Laser PrecisionPhotoimmunotherapy is an experimental technique that combines the immune system’s ability to target cancer cells precisely with laser energy’s ability to destroy them.
A newly developed assay may help researchers identify potential new drugs to protect kidney cells in order to prevent or treat chronic kidney disease, according to findings by Rush researchers published online April 9 in the Journal of the American Society of Nephrology.
Researchers at UC San Francisco and Rush University Medical Center may have found a predictor for a disorder affecting kidney transplant recipients that can accelerate organ failure, a discovery that eventually could allow for customized therapies and improved patient selection for transplant.
Dr. Antonio Bianco, a physician scientist working in the thyroid field, has joined Rush University Medical Center as professor of medicine, senior vice chair in the Department of Internal Medicine and division chief of endocrinology at Rush University Medical Center effective February 3rd.
Dr. Kim Williams, a nuclear cardiologist with a special interest in cardiovascular radiology and heart disease in kidney and cancer patients, has been appointed chief of cardiology at Rush University Medical Center.
The research shows that long term use of the such footwear, called “mobility shoes,” helped OA patients adapt their gait or how they walk, which improved knee loading, even when the mobility shoes were no longer worn.
A research team from Rush University Medical Center and Northwestern University has discovered that circadian rhythm disruption may be a factor in developing cirrhosis, also known as alcoholic liver disease, when combined with heavy alcohol consumption.